Douglas P. Kiel

Dr. Kiel currently serves as Director for the Musculoskeletal Research Center at the Marcus Institute for Aging Research of Hebrew SeniorLife and a Professor of Medicine in the Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School. He leads the Framingham Osteoporosis Study, is the former President of the American Society for Bone and Mineral Research, and serves in leadership roles for many other organizations including the NIH, National Osteoporosis Foundation, and the Joint Commission. Dr. Kiel’s research focuses on the epidemiology of osteoporosis and related fractures, including lifestyle factors, biomarkers, and genetic factors. He also heads the Geriomics program at the Marcus Institute that includes faculty and post-doctoral fellows appointed through Harvard Medical School who study the “omics” of age-related disease and the aging process itself as a part of the musculoskeletal Research Center. Dr. Kiel has conducted numerous clinical trials targeting the musculoskeletal system in academic and industry settings, and has published over 400 peer reviewed journal articles. In 2019 he received the Frederic C. Bartter Award given to an ASBMR member in recognition of outstanding clinical investigation in disorders of bone and mineral metabolism.